Press release
Low-Density Lipoprotein Test Market Size, Business Growth Updates, Trends, Industry Report And Forecast To 2033
Low-Density Lipoprotein Test Market
According to The Business Research Company's, The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.11 billion in 2023 to $8.46 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to research advancements in cardiovascular medicine, increased awareness of heart health, shift in treatment paradigms, clinical guidelines and recommendations, focus on preventive healthcare..
The low-density lipoprotein test market size is expected to see steady growth in the next few years. It will grow to $10.24 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing healthcare expenditure, aging population demographics, rise in cardiovascular disease burden, shift towards personalized medicine, healthcare policy and guidelines.. Major trends in the forecast period include rising cardiovascular disease prevalence, emphasis on preventive healthcare, personalized medicine and treatment, focus on health awareness and education, regulatory guidelines and recommendations..
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report
Market Drivers and Trends:
The rise in the prevalence of cardiovascular diseases is expected to propel the growth of the low-density lipoprotein test market going forward. Cardiovascular diseases refer to a type of condition that affects the heart or blood vessels. The LDL test is used to treat cardiovascular diseases by directly measuring low-density lipoprotein levels in the heart. For instance, in October 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, heart disease is the top cause of mortality in the United States for both genders and members of most racial and ethnic groups. Heart disease claimed almost 695,000 people in the United States in 2021, accounting for one in every five deaths. In 2020, the most common type of heart disease, coronary heart disease, killed 375,476 people. Therefore, the rise in the prevalence of cardiovascular diseases is driving the growth of the low-density lipoprotein test market.
Product innovations are a key trend gaining popularity in the low-density lipoprotein test markets. Major companies operating in the low-density lipoprotein test market are introducing innovative products to sustain their position in the market. For instance, in December 2021, Novartis AG, a Switzerland-based multinational pharmaceutical corporation, launched Leqvio (Inclisiran), a first-in-class siRNA (small interfering RNA therapy) to lower low-density lipoprotein cholesterol. This medication provides effective and sustained reductions in low-density lipoprotein cholesterol. Leqvio is the first and only small interfering RNA (siRNA) medication for lowering LDL-C (bad cholesterol) that has received FDA approval, requiring just two maintenance doses per year. For some patients with atherosclerotic cardiovascular disease (ASCVD) receiving maximally tolerated statin therapy, Leqvio offers an effective and long-lasting LDL-C decrease of up to 52% in comparison to placebo. Leqvio is a ground-breaking method to reduce LDL-C that also opens new opportunities for how healthcare systems can affect cardiovascular disease.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp
Major Key Players of the Market:
Abbott Laboratories; Qiagen N.V.; Randox Laboratories Ltd.; Eurofins Scientific SE; Danaher Corporation; Bio-Rad Laboratories Inc.; OPKO Health Inc.; Lincoln Diagnostics LLC; DiaSorin S.p.A.; Boster Biological Technology Ltd.; Rockland Immunochemicals Inc.; Sekisui Diagnostics LLC; DiaSys Diagnostic Systems GmbH; Eurolyser Diagnostica GmbH; Diazyme Laboratories Inc.; Cell Biolabs Inc; Home Access Health Corporation; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; Quest Diagnostics Incorporated; SpectraCell Laboratories Inc.; Siemens AG; Alfa Wassermann Inc.; Laboratory Corporation of America Holdings; Merck KGaA; F Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; BioVision Incorporated; Abcam plc; BioAssay Systems; BioChain Institute Inc.; BioLegend Inc.; Bioo Scientific LLC; Enzo Life Sciences Inc.; GenScript Biotech Corporation
Low-Density Lipoprotein Test Market 2024 Key Insights:
• The low-density lipoprotein test market will grow to $10.24 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%.
• Surge In Cardiovascular Diseases Propels Expansion Of Low-Density Lipoprotein Test Market
• Innovative Breakthrough Transforming The Landscape Of Low-Density Lipoprotein Test Markets
• North America was the largest region in the Low-Density Lipoprotein Test market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=9395&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Low-Density Lipoprotein Test Market Size, Business Growth Updates, Trends, Industry Report And Forecast To 2033 here
News-ID: 3750421 • Views: …
More Releases from The Business Research Company
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,…
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Security Analytics Market Through 2025?
The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of…
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025?
The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,…
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Remote Firmware Market Size By 2025?
The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.…
More Releases for Lipoprotein
Low-Density Lipoprotein Test Market: Major Trends Reshaping the Future of the In …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Low-Density Lipoprotein Test Industry Market Size Be by 2025?
The market size for the low-density lipoprotein test has seen a consistent increase over the past few years. It is anticipated to expand from its value of $8.52 billion in 2024 to $8.85 billion in 2025, marking a compound annual growth rate…
Emerging Trends Influencing The Growth Of The Low-Density Lipoprotein Test Marke …
The Low-Density Lipoprotein Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Low-Density Lipoprotein Test Market?
The market size of the low-density lipoprotein test has experienced consistent expansion in recent times. It's projected to increase from $8.52 billion in…
Key Trend Reshaping the Low-Density Lipoprotein Test Market Segments SegmentsSiz …
What industry-specific factors are fueling the growth of the low-density lipoprotein test Market Segments?
The increasing occurrence of cardiovascular diseases is predicted to fuel the expansion of the low-density lipoprotein test Market Segments. Cardiovascular conditions are those that impact the heart or blood vessels. The low-density lipoprotein (LDL) test plays a critical role in the treatment of these diseases by offering direct measurement of LDL levels in the heart. For example,…
Low Density Lipoprotein Test Kit Market Size 2024 to 2031.
Market Overview and Report Coverage
A Low Density Lipoprotein (LDL) Test Kit is a diagnostic tool used to measure the levels of LDL cholesterol in the blood. LDL cholesterol is often referred to as "bad" cholesterol and high levels of it can be a risk factor for cardiovascular diseases.
The current outlook of the Low Density Lipoprotein Test Kit Market is positive and is expected to grow at a CAGR…
Exploring the Global Low-Density Lipoprotein Test Market: A Comprehensive Overvi …
The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.11 billion in 2023 to $8.46 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to research advancements in cardiovascular medicine, increased awareness of heart health, shift in treatment paradigms, clinical guidelines and recommendations, focus on preventive healthcare..
The low-density lipoprotein…
Low Lipoprotein Market Size 2024 to 2031.
Market Overview and Report Coverage
KEYWORD will see significant growth in the coming years due to an increasing prevalence of cardiovascular diseases and rising awareness about the importance of maintaining low levels of lipoproteins in the body. The market is expected to grow at a CAGR of 7.80% during the forecasted period.
Several factors are driving the growth of the Low Lipoprotein Market, including advancements in medical technology, increasing healthcare…
